- Pelamed Pharmaceuticals had EBIT of $325 million in 2010. In addition, Pelamed had interest expenses of $125 million and a corporate tax rate of 40%. - a. What was Pelamed's 2010 net income? - b. What was the total of Pelamed's 2010 net income and interest payments? - c. If Pelamed had no debt, what would its 2010 net income have been? How does it compare to your answer in part (b)? - d. What was the amount of Pelamed's interest tax shield in 2010